RICE HALL JAMES & ASSOCIATES, LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$990,000
+23.1%
60,309
-0.4%
0.03%
+13.8%
Q3 2019$804,000
-3.1%
60,542
+2.7%
0.03%
+3.6%
Q2 2019$830,000
-19.3%
58,927
+5.4%
0.03%
-15.2%
Q1 2019$1,029,000
+2.9%
55,910
+46.1%
0.03%
-8.3%
Q4 2018$1,000,000
+77.0%
38,264
+55.4%
0.04%
+80.0%
Q3 2018$565,000
+20.0%
24,615
-0.4%
0.02%
+17.6%
Q2 2018$471,000
+15.2%
24,723
+1.7%
0.02%
+6.2%
Q1 2018$409,000
-4.7%
24,302
-14.0%
0.02%
-5.9%
Q4 2017$429,000
-14.2%
28,245
+1.2%
0.02%
-22.7%
Q3 2017$500,000
+9.9%
27,922
+0.1%
0.02%
+10.0%
Q2 2017$455,000
+17.6%
27,903
+1.0%
0.02%
+5.3%
Q1 2017$387,000
-9.8%
27,624
+2.7%
0.02%
-13.6%
Q4 2016$429,000
+15.3%
26,885
+20.3%
0.02%
+15.8%
Q3 2016$372,000
+50.6%
22,343
+1.2%
0.02%
+35.7%
Q2 2016$247,000
+32.8%
22,069
-0.8%
0.01%
+27.3%
Q1 2016$186,000
-11.4%
22,257
-1.5%
0.01%
-8.3%
Q4 2015$210,000
-15.3%
22,597
+2.9%
0.01%
-25.0%
Q3 2015$248,000
-14.8%
21,966
-4.3%
0.02%
-5.9%
Q2 2015$291,000
+23.3%
22,961
-9.5%
0.02%
+21.4%
Q1 2015$236,000
-33.3%
25,369
+2.7%
0.01%
-33.3%
Q4 2014$354,000
+39.9%
24,714
+1.5%
0.02%
+16.7%
Q3 2014$253,000
-35.0%
24,357
+1.3%
0.02%
-30.8%
Q2 2014$389,000
+1.0%
24,054
+1.5%
0.03%
-7.1%
Q1 2014$385,00023,7040.03%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Signpost Capital Advisors, LP 1,688,952$27,327,00010.37%
Palo Alto Investors LP 3,240,424$52,430,0003.90%
Parametrica Management Ltd 12,509$202,0001.53%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,740,400$28,160,0001.08%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 557,100$9,014,0001.07%
Westend Capital Management, LLC 64,086$841,0001.00%
WALL STREET ASSOCIATES 702,700$11,370,0000.98%
Baker Brothers Advisors 4,372,153$70,741,0000.87%
Iguana Healthcare Management, LLC 100,000$1,618,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,085,301$17,560,0000.71%
View complete list of VANDA PHARMACEUTICALS INC shareholders